Eric Smith
Judge · DISC type DcEric Smith serves as the Director of Translational Research for Immune Effector Cell Therapies at Dana-Farber Cancer Institute. An MD from the Icahn School of Medicine, he focuses on translating preclinical discoveries, especially cell-based therapies for myeloma, from the lab into clinical practice.
He is deeply engaged with the patient advocacy community, drawing inspiration from their stories to advance cell and gene therapy. Eric values scientific collaboration and mentorship, frequently crediting his colleagues and team for their collective success in research and patient care.
Dr. Smiths preclinical work has resulted in nine awarded or pending patents, with several products from his lab being translated into the clinic.
Read the full overview →How Eric shows up
They respond better to strong and respectful interactions. They take a lot of pride in personal achievements. More than the product, they care about the impact of the product.
Topics Eric cares about
Work history
Media appearances
DISC profile (public)
Dominance (D)
Dominance (D) reflects how goal and task oriented a person is, and their ability to accomplish results irrespective of how demanding the circumstances might be. Those scoring high tend to be motivated by winning, competition, and success.
Other Dana-Farber Cancer Institute Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.